Financials

  • Market Capitalization 273.31 M
  • Employee 35
  • Founded 2008
  • CEO N/A
  • Website www.inhibikase.com
  • Headquarter Delaware, United States
  • FIGI BBG005TP2339
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.82
Fiyat/satışlar oranı
43.33

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3404
SABS
SAB Biotherapeutics, Inc. - Common Stock
3.54 USD-1.67%-8.76%-9.23%+26.43%270.68 M USD
3411
MGNX
MacroGenics, Inc. - Common Stock
4.21 USD-1.86%-11.18%+1.45%+180.67%267.60 M USD
3419
ALXO
ALX Oncology Holdings Inc. - Common Stock
1.96 USD-2.00%-17.30%+23.27%+317.02%263.74 M USD
3431
TRDA
Entrada Therapeutics, Inc. - Common Stock
6.75 USD-0.74%-7.15%+3.37%-3.16%262.04 M USD

Haberler